| 000 | 01369 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513130020.0 | ||
| 264 | 0 | _c19971113 | |
| 008 | 199711s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s002800050693 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLevasseur, L M | |
| 245 | 0 | 0 |
_aCombined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1997 |
||
| 300 |
_a495-505 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aColonic Neoplasms _xpathology |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xpathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xpathology |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aGreco, W R | |
| 700 | 1 | _aRustum, Y M | |
| 700 | 1 | _aSlocum, H K | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 40 _gno. 6 _gp. 495-505 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002800050693 _zAvailable from publisher's website |
| 999 |
_c9305034 _d9305034 |
||